UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Restless legs syndrome in children

Sleep medicine, 2020-11, Vol.75, p.544-544

2020

Volltextzugriff (PDF)

Clinical variability of neuroacanthocytosis syndromes—a series of six patients with long follow-up

Clinical neurology and neurosurgery, 2016-08, Vol.147, p.78-83

2016

Volltextzugriff (PDF)

The clinical and neuroimaging studies in Holmes tremor

Acta neurologica Scandinavica, 2010-11, Vol.122 (5), p.360-366

2010

Volltextzugriff (PDF)

Frontotemporal dementia and parkinsonism linked to chromosome 17 - the first Polish family

European journal of neurology, 2011-03, Vol.18 (3), p.535-537

2011

Volltextzugriff (PDF)

Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation—a 5 year follow up

Metabolic brain disease, 2015-08, Vol.30 (4), p.1083-1085

2015

Volltextzugriff (PDF)

Camptocormia as a form of dystonia in Parkinson's disease

European journal of neurology, 2003-01, Vol.10 (1), p.107-108

2003

Volltextzugriff (PDF)

Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results

European journal of neurology, 2003-05, Vol.10 (3), p.313-317

2003

Volltextzugriff (PDF)

Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine

Parkinsonism & related disorders, 2023-08, Vol.113

2023

Volltextzugriff (PDF)

Pharmacokinetics of levodopa and 3-omd in patients with Parkinson's disease and motor fluctuations infected with Helicobacter pylori

Journal of the neurological sciences, 2013-10, Vol.333, p.e106-e106

2013

Volltextzugriff (PDF)

XAS database of reagents frequently used in structural biology

Acta crystallographica. Section A, Foundations and advances, 2023-08, Vol.79 (a2), p.C47-C47

2023

Volltextzugriff (PDF)

High-pressure studies of glucose/xylose isomerase – a protein used in the food industry

Acta crystallographica. Section A, Foundations and advances, 2023-08, Vol.79 (a2), p.C851-C851

2023

Volltextzugriff (PDF)

Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson's disease

Parkinsonism & related disorders, 2010-01, Vol.16 (1), p.73-74

2010

Volltextzugriff (PDF)

3.023 FREQUENCY OF THE MUTATIONS IN THE PARK2, PINK1 AND DJ-1 GENES IN POLISH PATIENTS WITH THE EARLY-ONSET PARKINSON DISEASE

Parkinsonism & related disorders, 2012, Vol.18, p.S174-S175

2012

Volltextzugriff (PDF)

F11 Self-awareness of involuntary movements and daily living disability in huntington's disease in comparison to Parkinson's disease and cervical dystonia

Journal of neurology, neurosurgery and psychiatry, 2010-09, Vol.81 (Suppl 1), p.A26-A26

2010

Volltextzugriff (PDF)

Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia

Parkinsonism & related disorders, 2023-08, Vol.113

2023

Volltextzugriff (PDF)

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene

PloS one, 2013-04, Vol.8 (4), p.e61074-e61074

2013

Volltextzugriff (PDF)

Restless legs syndrome in children and adolescents – an underestimated clinical problem? A review of the literature

European journal of paediatric neurology, 2008, Vol.12, p.S49-S49

2008

Volltextzugriff (PDF)

Pre-hospital delays and intravenous thrombolysis in urban and rural areas

Acta neurologica Scandinavica, 2012-09, Vol.126 (3), p.171-177

2012

Volltextzugriff (PDF)

Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People

Drugs & aging, 2018-07, Vol.35 (7), p.677-677

2018

Volltextzugriff (PDF)

Interleukin-10 ( IL10 ) and tumor necrosis factor α ( TNF ) gene polymorphisms in Parkinson's disease patients

Parkinsonism & related disorders, 2008-12, Vol.14 (8), p.636-640

2008

Volltextzugriff (PDF)

Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens

Neurological sciences, 2005-04, Vol.26 (1), p.32-39

2005

Volltextzugriff (PDF)

2.101 NEUROCAM – AUTOMATED ASSISTANCE TO NEUROLOGICAL PRACTICIONERS

Parkinsonism & related disorders, 2012, Vol.18, p.S101-S101

2012

Volltextzugriff (PDF)

2.102 AUTOMATIC ASSESSMENT OF THE MOTOR STATE OF PARKINSON'S DISEASE PATIENTS

Parkinsonism & related disorders, 2012, Vol.18, p.S101-S102

2012

Volltextzugriff (PDF)

A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke

Cerebrovascular diseases (Basel, Switzerland), 2003-01, Vol.15 (4), p.289-300

2003

Volltextzugriff (PDF)

Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients

Neurologia i neurochirurgia polska, 2013, Vol.47 (4), p.319-324

2013

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(211)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(224)
Polnisch
(20)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Restless legs syndrome in children

Clinical variability of neuroacanthocytosis syndromes—a series of six patients with long follow-up

The clinical and neuroimaging studies in Holmes tremor

Frontotemporal dementia and parkinsonism linked to chromosome 17 - the first Polish family

Changing phenotypic expression in a patient with a mitochondrial encephalopathy due to 13042G>A de novo mutation—a 5 year follow up

Camptocormia as a form of dystonia in Parkinson's disease

Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results

Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine

Pharmacokinetics of levodopa and 3-omd in patients with Parkinson's disease and motor fluctuations infected with Helicobacter pylori

XAS database of reagents frequently used in structural biology

High-pressure studies of glucose/xylose isomerase – a protein used in the food industry

Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson's disease

3.023 FREQUENCY OF THE MUTATIONS IN THE PARK2, PINK1 AND DJ-1 GENES IN POLISH PATIENTS WITH THE EARLY-ONSET PARKINSON DISEASE

F11 Self-awareness of involuntary movements and daily living disability in huntington's disease in comparison to Parkinson's disease and cervical dystonia

Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene

Restless legs syndrome in children and adolescents – an underestimated clinical problem? A review of the literature

Pre-hospital delays and intravenous thrombolysis in urban and rural areas

Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People

Interleukin-10 ( IL10 ) and tumor necrosis factor α ( TNF ) gene polymorphisms in Parkinson's disease patients

Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens

2.101 NEUROCAM – AUTOMATED ASSISTANCE TO NEUROLOGICAL PRACTICIONERS

2.102 AUTOMATIC ASSESSMENT OF THE MOTOR STATE OF PARKINSON'S DISEASE PATIENTS

A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke

Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients

Suchergebnisse filtern